2020

A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma​
​Clinical Cancer Research | AACR

Dissecting racial disparities in multiple myeloma
Blood Cancer Journal

Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies​
Journal of Clinical Oncology 

Prediagnosis dietary pattern and survival in patients with multiple myeloma
International Journal of Cancer

Bone marrow niches in haematological malignancies
Nature Reviews. Cancer

The microenvironment in myeloma
Current Opinion in Oncology

Clinical Controversies in the Management of Smoldering Multiple Myeloma
American Society of Clinical Oncology Educational Book ​| ASCO

Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
Nature Cancer

Intensification and consolidation therapy in multiple myeloma in the current era
The Lancet. Haematology

​The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action
Cancer Epidemiology, Biomarkers, and Prevention ​| AACR

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients
​Blood

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression
Journal of Clinical Oncology

Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
Nature Communications

Monoclonal Gammopathy of Undetermined Significance (MGUS)-Not So Asymptomatic after All
Cancers (Basel)

Genome instability in multiple myeloma
Leukemia

Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia
Journal of Clinical Oncology

Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia
Leukemia Research

Progression signature underlies clonal evolution and dissemination of multiple myeloma
Blood

Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
Cell

Pro-organic radical contrast agents ("pro-ORCAs") for real-time MRI of pro-drug activation in biological systems
Polymer Chemistry